Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Periprocedural Stroke and Myocardial Infarction as Risks for Long-Term Mortality in CRESTCirculation: Cardiovascular Quality and Outcomes.  11:e004663. 2018
2018 Drugs don’t work in patients who don’t take themJournal of Clinical Hypertension.  20:1504-1506. 2018
2018 Race, sex, age, and regional differences in the association of obstructive sleep apnea with atrial fibrillation: Reasons for geographic and racial differences in stroke studyJournal of Clinical Sleep Medicine.  14:1485-1493. 2018
2018 N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke studyBMC Cardiovascular Disorders.  18. 2018
2018 Long-term effects of an intensive lifestyle intervention on electrocardiographic criteria for left ventricular hypertrophy: The look AHEAD trialAmerican Journal of Hypertension.  31:541-548. 2018
2018 Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension fromthe Systolic Blood Pressure InterventionTrialJournal of Hypertension.  36:904-915. 2018
2018 Serum Tumor Necrosis Factor-alpha associates with Myocardial Oxygen Demand and Exercise Tolerance in Postmenopausal Women.International Journal of Exercise Science.  11:42-54. 2018
2017 The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical TrialJournal of Bone and Mineral Research.  32:2278-2287. 2017
2017 The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial)Journal of Clinical Hypertension.  19:1152-1161. 2017
2017 Adherence to high-intensity statins following a myocardial infarction hospitalization among medicare beneficiariesJAMA Cardiology.  2:890-895. 2017
2017 Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the National Death Index: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) studyJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  6. 2017
2016 Orthostatic changes in systolic blood pressure among SPRINT participants at baselineJournal of the American Society of Hypertension.  10:847-856. 2016
2016 What is the association of lipid levels and incident stroke?International Journal of Cardiology.  220:890-894. 2016
2016 A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patientsPharmacological Research.  111:343-356. 2016
2016 Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke studyJournal of the American Society of Hypertension.  10:702-713.e4. 2016
2016 Gender, race, age, and regional differences in the association of pulse pressure with atrial fibrillation: the Reasons for Geographic and Racial Differences in Stroke studyJournal of the American Society of Hypertension.  10:625-632.e1. 2016
2016 Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke studyJournal of the American Society of Hypertension.  10:578-586.e5. 2016
2016 Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT)Journal of Hypertension.  34:1224-1231. 2016
2016 Burden of Coronary Heart Disease Rehospitalizations Following Acute Myocardial Infarction in Older AdultsCardiovascular Drugs and Therapy.  30:323-331. 2016
2016 Systolic blood pressure response after high-intensity interval exercise is independently related to decreased small arterial elasticity in normotensive African American womenCanadian Journal of Applied Physiology.  41:484-490. 2016
2016 Antidepressant Medication Use and Its Association With Cardiovascular Disease and All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) StudyAnnals of Pharmacotherapy.  50:253-261. 2016
2016 Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysisPharmacological Research.  103:236-252. 2016
2016 Recruitment strategies and challenges in a large intervention trial: Systolic Blood Pressure Intervention TrialClinical Trials.  13:319-330. 2016
2015 Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011Journal of the American College of Cardiology.  66:1864-1872. 2015
2015 Tibolone decreases Lipoprotein(a) levels in postmenopausal women: A systematic review and meta-analysis of 12 studies with 1009 patientsAtherosclerosis.  242:87-96. 2015
2015 Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trialDiabetologia.  58:1803-1813. 2015
2015 Statin therapy and plasma coenzyme Q10 concentrations - A systematic review and meta-analysis of placebo-controlled trialsPharmacological Research.  99:329-336. 2015
2015 Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke StudyAnnals of Behavioral Medicine2015
2015 Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke StudyAnnals of Behavioral Medicine.  49:802-808. 2015
2015 Systolic blood pressure control among individuals with type 2 diabetes: A comparative effectiveness analysis of three interventionsAmerican Journal of Hypertension.  28:995-1009. 2015
2015 Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) TrialJournal of the Academy of Nutrition and Dietetics.  115:731-742. 2015
2015 Race-sex differences in the management of hyperlipidemia: The reasons for geographic and racial differences in stroke studyAmerican Journal of Preventive Medicine.  48:520-527. 2015
2015 Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: The look AHEAD studyObesity Research.  23:565-572. 2015
2015 Coronary Heart Disease Risk Factors and Outcomes in the Twenty-First Century: Findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyCurrent Hypertension Reports.  17. 2015
2015 Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) StudyClinical Neuropsychologist.  29:466-486. 2015
2015 Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trialsMayo Clinic Proceedings.  90:24-34. 2015
2015 Is pulse pressure an independent risk factor for incident stroke, REasons for geographic and racial differences in strokeAmerican Journal of Hypertension.  28:987-994. 2015
2015 Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?Hypertension.  65:991-992. 2015
2014 Secular changes in rates of coronary heart disease, fatal coronary heart disease, and out-of-hospital fatal coronary heart diseaseInternational Journal of Cardiology.  174:436-439. 2014
2014 Achievement of optimal medical therapy goals for U.S. adults with coronary artery disease: Results from the REGARDS Study (REasons for Geographic and Racial Differences in Stroke)Journal of the American College of Cardiology.  63:1626-1633. 2014
2014 Impact of weight loss on ankle-brachial index and interartery blood pressuresObesity Research.  22:1032-1041. 2014
2014 Arterial elasticity, strength, fatigue, and endurance in older womenBioMed Research International.  2014. 2014
2014 Prehypertension and incident acute coronary heart disease in the reasons for geographic and racial differences in stroke (Regards) studyAmerican Journal of Hypertension.  27:245-251. 2014
2014 Aspirin as Primary Prevention of Acute Coronary Heart Disease Events.British Journal of Medicine and Medical Research.  4:5357-5367. 2014
2014 Cognitive effects of statin medicationsCNS Drugs.  28:411-419. 2014
2014 Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetesAnnals of Epidemiology.  24:581-587. 2014
2014 Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: A secondary analysis of the Look AHEAD randomised clinical trialLancet Diabetes and Endocrinology.  2:801-809. 2014
2014 Hemodynamic and echocardiographic profiles in african american compared with white offspring of hypertensive parents: The HyperGEN studyAmerican Journal of Hypertension.  27:21-26. 2014
2014 Implications of Look AHEAD for clinical trials and clinical practiceDiabetes, Obesity and Metabolism.  16:1183-1191. 2014
2014 Is pulse pressure an independent risk factor for incident acute coronary heart disease events? the REGARDS studyAmerican Journal of Hypertension.  27:555-563. 2014
2014 Objective sleep, a novel risk factor for alterations in kidney function: The CARDIA studySleep Medicine.  15:1140-1146. 2014
2014 Statin underuse and low prevalence of LDL-C control among U.S. Adults at high risk of coronary heart diseaseAmerican Journal of the Medical Sciences.  348:108-114. 2014
2013 Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke studyJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.  2:e000447. 2013
2013 Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetesDiabetes Care.  36:2734-2740. 2013
2013 Longitudinal determinants of left ventricular mass and geometry: The coronary artery risk development in young adults (CARDIA) studyCirculation: Cardiovascular Imaging.  6:769-775. 2013
2013 Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010American Journal of Cardiology.  112:664-670. 2013
2013 Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: An observational studyBMC Health Services Research.  13. 2013
2013 Four-year change in cardiorespiratory fitnessandinfluenceonglycemiccontrol in adults with type 2 diabetes in a randomized trial: The look AHEAD trialDiabetes Care.  36:1297-1303. 2013
2013 Associations between arterial elasticity and markers of inflammation in healthy older womenJournals of Gerontology, Series A.  68:382-388. 2013
2013 Changes in Vascular Hemodynamics in Older Women Following 16 Weeks of Combined Aerobic and Resistance TrainingJournal of Clinical Hypertension.  15:241-246. 2013
2013 Assessment tools for unrecognized myocardial infarction: A cross-sectional analysis of the REasons for geographic and racial differences in stroke populationBMC Cardiovascular Disorders.  13. 2013
2013 Primary prophylactic aspirin use and incident stroke: Reasons for geographic and racial differences in stroke studyJournal of Stroke and Cerebrovascular Diseases.  22:500-507. 2013
2012 Association of race and sex with risk of incident acute coronary heart disease eventsJournal of the American Medical Association.  308:1768-1774. 2012
2012 Effects of antihypertensive drugs on arterial stiffnessCardiology in Review.  20:259-263. 2012
2012 Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney diseaseAmerican Journal of Hypertension.  25:789-796. 2012
2012 Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journalsInternational Journal of Obesity.  36:977-981. 2012
2012 Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patientsJournal of the American Society of Hypertension.  6:66-72. 2012
2012 Is randomization to placebo safe? Risk in placebo-controlled angina trials: Angina risk meta-analysisCardiology.  120:174-181. 2012
2012 Subclinical, hemodynamic, and echocardiographic abnormalities of high pulse pressure in hypertensive and non-hypertensive adults.American Journal of Cardiovascular Disease.  2:309-317. 2012
2011 A clustering analysis of lipoprotein diameters in the metabolic syndromeLipids in Health and Disease.  10. 2011
2011 The Global Burden of Cardiovascular Disease: The Role of Endothelial Function and Arterial Elasticity in Cardiovascular Disease as Novel and Emerging BiomarkersCurrent Cardiovascular Risk Reports.  5:187-195. 2011
2011 High-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering drugs and diet network (GOLDN): An interventional studyLipids in Health and Disease.  10. 2011
2011 Four-year weight losses in the look AHEAD study: Factors associated with long-term successObesity Research.  19:1987-1998. 2011
2011 Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetSLipids in Health and Disease.  10. 2011
2011 Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trialCirculation.  123:2571-2578. 2011
2011 Prehypertension, racial prevalence and its association with risk factors: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) studyAmerican Journal of Hypertension.  24:194-199. 2011
2010 Effect of the Look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetesDiabetes Care.  33:1153-1158. 2010
2010 Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS studyEthnicity and Disease.  20:282-289. 2010
2010 The association of statin use and statin type and cognitive performance: Analysis of the reasons for geographic and racial differences in stroke (REGARDS) studyClinical Cardiology.  33:280-288. 2010
2010 Comparison of Postprandial Responses to a High-Fat Meal in Hypertriglyceridemic Men and Women before and after Treatment with Fenofibrate in the Genetics and Lipid Lowering Drugs and Diet Network (GOLDN) Study.SRX pharmacology.  2010:485146. 2010
2009 Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?Hypertension.  54:954-955. 2009
2009 TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate.Diabetology & Metabolic Syndrome.  1:16. 2009
2009 Smoking, inflammatory patterns and postprandial hypertriglyceridemiaAtherosclerosis.  203:633-639. 2009
2009 Clinical benefits versus shortcomings of diltiazem once-daily in the chronotherapy of cardiovascular diseasesExpert Opinion on Pharmacotherapy.  10:485-491. 2009
2008 Measurement characteristics of the ankle-brachial index: Results from the action for health in diabetes studyVascular Medicine.  13:225-233. 2008
2008 Weight loss treatment influences untreated spouses and the home environment: Evidence of a ripple effectInternational Journal of Obesity.  32:1678-1684. 2008
2008 Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?Preventive Medicine.  47:161-166. 2008
2008 The risks associated with short-term placebo-controlled antihypertensive clinical trials: A descriptive meta-analysisJournal of Human Hypertension.  22:659-668. 2008
2008 Association between endothelial biomarkers and arterial elasticity in young adults: the CARDIA StudyJournal of the American Society of Hypertension.  2:70-79. 2008
2008 Vascular stiffness and the "chicken-or-the-egg" questionHypertension.  51:177-178. 2008
2008 Analysis of US food and drug administration warning letters: False promotional claims relating to prescription and over-the-counter medicationsPharmaceutical Medicine.  22:119-125. 2008
2008 Endothelial function in young adult survivors of childhood acute lymphoblastic leukemiaJournal of Pediatric Hematology/Oncology.  30:20-25. 2008
2007 Importance and challenges of studying marketed drugs: What is a phase IV study? common clinical research designs, registries, and self-reporting systemsJournal of Clinical Pharmacology.  47:1074-1086. 2007
2007 Diagnostic criteria and adjudication process both determine published event-rates: The ACTION trial experienceControlled Clinical Trials.  28:720-729. 2007
2007 Health Knowledge About Symptoms of Heart Attack and Stroke in Adult Survivors of Childhood Acute Lymphoblastic LeukemiaAnnals of Epidemiology.  17:778-781. 2007
2006 Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) studyDiabetes and Vascular Disease Research.  3:202-215. 2006
2006 Consent for genetics studies among clinical trial participants: Findings from action for health in diabetes (Look AHEAD)Clinical Trials.  3:443-456. 2006
2006 Clinical trial design issues: At least 10 things you should look for in clinical trialsJournal of Clinical Pharmacology.  46:1106-1115. 2006
2006 Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemiaCancer.  107:1303-1312. 2006
2006 Antihypertensive safety and efficacy and physicians and patient satisfaction: Results from a phase 4 practice-based clinical experience trial with diltiazem LAAdvances in Therapy.  23:284-294. 2006
2006 Pharmacogenetics of antihypertensive treatmentVascular Pharmacology.  44:107-118. 2006
2006 Cardiovascular events in hypertension trials: A focus on perindoprilCardiology in Review.  23:44-45. 2006
2005 Is HDL cholesterol an independent cardiovascular disease risk factor?Cardiology in Review.  22:42-43. 2005
2005 The obesity epidemic: New therapeutic approachesCardiology in Review.  22:42-43. 2005
2005 Part 3: Overview of study designsCardiology in Review.  22:44-45. 2005
2005 Long-acting diltiazem HCL for the chronotherapeutic treatment of hypertension and chronic stable angina pectorisExpert Opinion on Pharmacotherapy.  6:765-776. 2005
2005 Essential characteristics of clinical research and strength of evidenceCardiology in Review.  22:41-43. 2005
2005 Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectorisAmerican Heart Journal.  149:e1. 2005
2004 Clinical research: Definitions, "anatomy and physiology," and universal truthCardiology in Review.  21:44-47. 2004
2004 Polypharmacy - The good, the bad, and the uglyCardiology in Review.  21:34. 2004
2004 Determinants of radial artery pulse wave analysis in asymptomatic individualsAmerican Journal of Hypertension.  17:647-653. 2004
2003 Diltiazem Hydrochloride: New Technologies and Evolution of DiltiazemClinical Cardiology.  26. 2003
2003 Revisiting erectile dysfunction in cardiovascular patientsCardiology in Review.  20:42-43. 2003
2003 Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular eventsAmerican Journal of Hypertension.  16:265-269. 2003
2003 Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertensionAmerican Journal of Hypertension.  16:51-58. 2003
2002 The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery diseaseJournal of the American College of Cardiology.  40:2006-2012. 2002
2002 Hypertension syndrome and cardiovascular eventsSendrom -Istanbul-.  14:38-46. 2002
2002 Effect of doxazosin on arterial elasticity: Functional versus structural changesJournal of Clinical Pharmacology.  42:1105-1108. 2002
2002 Extended-release fluvastatin 80 mg shows greater efficacy, with comparable tolerability, versus immediate-release fluvastatin 40 mg for once daily treatment of primary hypercholesterolaemiaBritish Journal of Cardiology.  9:469-475. 2002
2002 Safety of PDE 5 inhibition in patients with cardiovascular diseaseCardiology in Review.  19:32-33. 2002
2002 SERMs revisitedCardiology in Review.  19:42. 2002
2001 Arterial compliance abnormalities in isolated systolic hypertensionAmerican Journal of Hypertension.  14:1007-1011. 2001
2001 Low-density lipoprotein size, pravastatin treatment, and coronary eventsJournal of the American Medical Association.  286:1468-1474. 2001
2001 Blood pressure and arterial compliance in young adults: The Minnesota Children's Blood Pressure StudyAmerican Journal of Hypertension.  14:200-205. 2001
2001 Hypertension syndrome and cardiovascular events: High blood pressure is only one risk factorPostgraduate Medicine.  110:29-36. 2001
2001 Safety of combination therapy for treatment of dyslipidemiaCardiology in Review.  18:37-38. 2001
2001 Treating hypertension in the elderly - Whom to treat, when, and with what?Journal of Clinical Hypertension.  3:103-109. 2001
2000 Will angiotensin receptor blockers play a role in heart failure treatment?Cardiology in Review.  17:36-37. 2000
2000 On Arterial Physiology, Pathophysiology of Vascular Compliance, and Cardiovascular DiseaseHeart Disease.  2:375-379. 2000
2000 Angiotensin converting enzyme inhibitors: Are they preferred first-line therapy?Current Hypertension Reports.  2:392-397. 2000
2000 Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemiaClinical Cardiology.  23:524-529. 2000
1999 Circadian Variations and Chronotherapeutic Implications for Cardiovascular Management: A Focus on COER VerapamilHeart Disease.  1:226-232. 1999
1999 New physiologic therapy for diabetesCardiology in Review.  16:10. 1999
1999 Prospects for therapy of nitrate toleranceLancet.  353:1545-1546. 1999
1999 Anti-ischemic effects of Amlodipine in patients with stable angina pectoris and myocardial ischemia during daily lifeAmerican Journal of Cardiology.  83:1117-1119. 1999
1999 Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectorisAmerican Journal of Cardiology.  83:507-514. 1999
1999 Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial complianceHypertension.  33:1392-1398. 1999
1998 Hormone replacement therapy: Should it be routine?Cardiology in Review.  15:19-20. 1998
1998 Clinical trials of herbal supplements to beginCardiology in Review.  15:61. 1998
1998 Sildenafil: Possible pitfalls for the heart patientCardiology in Review.  15:54. 1998
1998 Novel approaches to heart failureCardiology in Review.  15:15-16. 1998
1998 Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trialAnnals of Internal Medicine.  129:681-689. 1998
1998 Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trialJournal of the American College of Cardiology.  32:140-146. 1998
1998 Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectorisClinical Cardiology.  21:483-490. 1998
1998 Chronotherapeutics in cardiovascular diseaseBlood Pressure Monitoring.  3:53-57. 1998
1998 Estrogen/progestin therapy: Putting the HERS results in contextCardiology in Review.  15:55. 1998
1998 Hypertension, hypertrophy, hormones, and the heartAmerican Heart Journal.  135. 1998
1998 Single-pill combination therapyCardiology in Review.  15:8. 1998
1998 The importance of arterial compliance in cardiovascular drug therapyJournal of Clinical Pharmacology.  38:202-212. 1998
1998 The relevance of T-type calcium antagonists: A profile of mibefradilJournal of Clinical Pharmacology.  38:659-669. 1998
1998 Toward the ideal target goal for lowering cholesterolCardiology in Review.  15:43. 1998
1997 Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectorisAmerican Journal of Cardiology.  80:1546-1550. 1997
1997 Advances in antiplatelet therapy (continued)Cardiology in Review.  14:52. 1997
1997 Beta blocking agents in congestive heart failureCardiology in Review.  14:20-21. 1997
1997 New treatment options for diabetes mellitusCardiology in Review.  14:17. 1997
1997 Vascular compliance and cardiovascular disease: A risk factor or a marker?American Journal of Hypertension.  10:1175-1189. 1997
1997 The time course of left ventricular remodeling after acute myocardial infarctionAmerican Journal of Cardiology.  80:506-507. 1997
1997 Antianginal response to once-daily diltiazem CD in patients receiving concomitant β-blockers, long-acting nitrates, or bothPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  17:760-766. 1997
1997 Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectorisAmerican Journal of Cardiology.  79:1401-1405. 1997
1997 Eccentric dosage regimen for isosorbide dinitrateAmerican Family Physician.  55. 1997
1997 Eccentric dosage regimen for isosorbide dinitrate.American Family Physician.  55:57-58. 1997
1997 Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectorisJournal of Clinical Pharmacology.  37:53-57. 1997
1996 Chronobiology and chronotherapeuticsCardiology in Review.  13:13-17. 1996
1996 Atherosclerosis: Risk factors and the vascular endotheliumAmerican Heart Journal.  131:379-384. 1996
1996 The efficacy and safety of Pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dlAmerican Journal of Cardiology.  77:83-85. 1996
1996 The placebo effect in cardiovascular diseaseAmerican Heart Journal.  132:1207-1221. 1996
1995 Nisoldipine coat core as concomitant therapy in chronic stable angina pectorisAmerican Journal of Cardiology.  75. 1995
1995 Antianginal and Antiischemic Efficacy of Monotherapy Extended‐Release Nisoldipine (Coat Core) in Chronic Stable AnginaJournal of Clinical Pharmacology.  35:780-784. 1995
1995 ReplyAmerican Heart Journal.  129:1223-1224. 1995
1995 The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertensionClinical Therapeutics.  17:296-312. 1995
1995 The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertensionClinical Therapeutics.  17:12-29. 1995
1994 Mononitrates: Defining the ideal long-acting nitrateClinical Therapeutics.  16:130-139. 1994
1994 Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectorisAmerican Journal of Cardiology.  74:9-17. 1994
1994 Uniformity of captopril benefit in the SAVE study: Subgroup analysisEuropean Heart Journal.  15:2-8. 1994
1994 Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectorisAmerican Journal of Cardiology.  73:1165-1168. 1994
1994 Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectorisAmerican Journal of Cardiology.  73:213-218. 1994
1994 Phenomenon of nitrate toleranceAmerican Heart Journal.  128:137-146. 1994
1994 The role of coronary tone and increased demand in daily ischemia [1]Circulation.  89:2454-2455. 1994
1993 Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectorisAmerican Journal of Cardiology.  72:1249-1256. 1993
1993 Is the site of maximal coronary artery narrowing the culprit for future myocardial infarction?American Journal of Cardiology.  72:861-862. 1993
1993 Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS)Circulation.  88:92-100. 1993
1993 Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectorisJournal of the American College of Cardiology.  21:1605-1611. 1993
1993 Endothelium-derived vasoactive substances in myocardial ischemiaPrimary cardiology.  19:12-14. 1993
1993 Subsets of ambulatory myocardial ischemia based on heart rate activity: Circadian distribution and response to anti-ischemic medicationCirculation.  88:92-100. 1993
1992 Amlodipine combined with beta blockade for chronic angina: Results of a multicenter, placebo‐controlled, randomized double‐blind studyClinical Cardiology.  15:519-524. 1992
1992 Safety And Efficacy of Metoprolol in the Treatment of Hypertension in the ElderlyJournal of the American Geriatrics Society.  40:354-358. 1992
1991 Clinical aspects of silent myocardial ischemia in ChinaAmerican Journal of Cardiology.  67:1146-1147. 1991
1991 Exposing Patients With Chronic, Stable, Exertional Angina to Placebo Periods in Drug TrialsJournal of the American Medical Association.  265:1550-1554. 1991
1991 Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectorisCirculation.  84:2398-2408. 1991
1991 Update on Nitrate TherapyJournal of Clinical Pharmacology.  31:697-701. 1991
1990 Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptomsCirculation.  82:1962-1972. 1990
1990 Long‐Term Therapy with Benazepril in Patients with Congestive Heart Failure: Effects on Clinical Status and Exercise ToleranceJournal of Clinical Pharmacology.  30:1106-1111. 1990
1990 The risk factor profile for patients with asymptomatic myocardial ischemiaJournal of applied cardiology.  5:239-244. 1990
1990 Update on nitrate therapy: Reexamination of tolerance issues and efficacy endpoints of long-acting productsHospital formulary.  25:42-49. 1990
1989 Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patientsAmerican Journal of Cardiology.  63. 1989
1989 Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprololAmerican Journal of Cardiology.  63. 1989
1989 Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable anginaJournal of the American College of Cardiology.  13:786-793. 1989
1989 Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension.American Journal of Hypertension.  2:154-157. 1989
1989 Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectorisAmerican Heart Journal.  118:1127-1128. 1989
1989 Predictors of left ventricular hypertrophy in patients with essential hypertensionClinical Cardiology.  12:129-132. 1989
1989 Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients with Dilevalol and Metoprolol—A Double Blind Randomized StudyJournal of Clinical Pharmacology.  29:791-797. 1989
1989 Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertensionAmerican Journal of Hypertension.  2:154-157. 1989
1989 Silent myocardial ischemia: Improvement with nisoldipine therapySouthern Medical Journal.  82:32-34. 1989
1989 The Efficacy and Safety of Dilevalol in Patients with Chronic Stable Angina PectorisJournal of Clinical Pharmacology.  29:983-988. 1989
1989 The Impact of Antianginal Drug Therapy on Asymptomatic Myocardial IschemiaJournal of Clinical Pharmacology.  29:722-727. 1989
1988 Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectorisAmerican Journal of Cardiology.  62:518-522. 1988
1988 Clinical assessment of beta blockadeClinical Cardiology.  11:311-316. 1988
1988 Dilevalol compared to metoprolol for treatment of hypertension: A multicenter trialJournal of Cardiovascular Pharmacology.  11. 1988
1988 Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarctionAmerican Journal of Cardiology.  61:21-25. 1988
1988 Relation of results of exercise stress tests in young women to phases of the menstrual cycleAmerican Journal of Cardiology.  61:197-199. 1988
1987 A paradoxical response to arrhythmia therapyHospital Practice.  22:225-226. 1987
1986 The role of exercise testing in the identification of patients with silent myocardial ischemiaCardiology Clinics.  4:705-715. 1986
1985 Management of cardiac arrhythmiasHospital Practice.  20:127-148. 1985
1984 Exercise-induced S-T segment alterations.Cardiology Clinics.  2:337-347. 1984
1984 Predischarge post-myocardial infarction testing: exercise electrocardiography.Cardiology Clinics.  2:379-390. 1984
1984 Symposium on clinical exercise testing. Introduction and overview.Cardiology Clinics.  2:311-317. 1984
1984 Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertensionJournal of Cardiovascular Pharmacology.  6:S1105-S1108. 1984
1983 Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmiasAmerican Journal of Cardiology.  52:992-995. 1983
1982 Pulmonary valve echogramAmerican Journal of Cardiology.  49:1085-1086. 1982
1982 The independent impact of M-mode echocardiography on the diagnosis of suspected endocarditisJournal of Cardiovascular Ultrasonography.  1:271-275. 1982
1982 The rhythms of aging. What new do we know from Holter monitoring?Chest.  81:266-267. 1982
1981 An automated system for blood pressure determination during exerciseCirculation.  63:348-353. 1981
1981 Bayes' theorem in perspective: Toward improved interpretation of the exercise testAmerican Heart Journal.  101:116-117. 1981
1980 Cardiovascular and sympathetic reactions to in-flight emergency responses among base fire fightersAviation, Space, and Environmental Medicine.  51:788-792. 1980
1980 Arrhythmias detected by ambulatory monitoring. Lack of correlation with symptoms of dizziness and syncopeChest.  77:722-725. 1980
1980 Chloral hydrate overdose and cardiac arrhythmiasChest.  77:232-235. 1980
1980 Exercise and coronary artery diseaseThe Journal of the Florida Medical Association.  67:373-377. 1980
1979 When cardiac patients become surgical patientsHospital Practice.  14:165-173. 1979
1979 Electrocardiogram of the month. A node of caution.Journal- Louisiana State Medical Society.  131:311-312. 1979
1979 Preanesthetic Management of the Hypertensive PatientNew England Journal of Medicine.  301:942. 1979
1979 Electrocardiogram of the month. The breaking point.Journal- Louisiana State Medical Society.  131. 1979
1979 Electrocardiogram of the month: run silent run deep.Journal- Louisiana State Medical Society.  131. 1979
1979 Three is company.Journal- Louisiana State Medical Society.  131. 1979
1979 Atrial fibrillatory wave size and etiology of heart diseaseAmerican Heart Journal.  98:274. 1979
1979 Echocardiographic incidence of pericardial effusion in patients resuscitated by emergency medical techniciansJACEP.  8:6-8. 1979
1979 Occurrence of frequent complex arrhythmias detected by ambulatory monitoring. Findings in an apparently healthy asymptomatic elderly populationChest.  75:565-568. 1979
1978 Heart rate response to 'fright stress'Heart & Lung: The Journal of Acute and Critical Care.  7:1006-1010. 1978
1978 The electrocardiogram in patients with congenital absence of the pectoralis major muscle.Journal- Louisiana State Medical Society.  130:237-241. 1978
1978 Twenty-four hours with the happy Holter.Journal- Louisiana State Medical Society.  130. 1978
1978 Electrocardiogram of the month: up, up and away.Journal- Louisiana State Medical Society.  130. 1978
1978 Problems of dental patients with cardiovascular diseaseRivista italiana di stomatologia.  47:64-71. 1978
1978 Heartbreak or headache?Journal- Louisiana State Medical Society.  130. 1978
1978 Pulmonary valve echography: Review and updateMedical ultrasound.  2:26-32. 1978
1978 Traumatic coronary artery fistulaSouthern Medical Journal.  71:649-651. 1978
1977 Electrocardiogram of the month. Uncommon cause for pause.Journal- Louisiana State Medical Society.  129. 1977
1977 Ventricular asynergyHeart & Lung: The Journal of Acute and Critical Care.  6:817-824. 1977
1977 Electrocardiogram of the month: A message in massage.Journal- Louisiana State Medical Society.  129. 1977
1977 A heart matter or the gallbladder?Journal- Louisiana State Medical Society.  129. 1977
1977 The pre-excitation syndromes.Journal- Louisiana State Medical Society.  129. 1977
1977 Atrial flutter. Tracing an elusive arrhythmiaPostgraduate Medicine.  62:61-67. 1977
1977 Posterior leaflet motion in mitral stenosisChest.  71:87-88. 1977
1977 Pulmonary valve fluttering in subpulmonic ventricular septal defectAmerican Heart Journal.  94:3-5. 1977
1977 The arrhythmogenic effect of static electricity on the dog heartAmerican Heart Journal.  93:496-500. 1977
1977 The problems of patients with cardiovascular disease undergoing dental treatment.Journal of the American Dental Association.  94:1158-1162. 1977
1976 Accentuate the negative - eliminate the positive.Journal- Louisiana State Medical Society.  128. 1976
1976 Right cervical aortic arch and aortic stenosis: a case report.Journal- Louisiana State Medical Society.  128:281-283. 1976
1976 What the internist should know about echocardiography.Journal of the Mississippi State Medical Association.  17:291-294. 1976
1976 Electrocardiogram of the month.Journal- Louisiana State Medical Society.  128. 1976
1976 Illustrative echocardiogram: late mitral valve opening in aortic regurgitation.Chest.  70:70-71. 1976
1976 Electrocardiogram of the month. Battle of the bulge.Journal- Louisiana State Medical Society.  128. 1976
1976 Late mitral valve opening in aortic regurgitationChest.  70:70-71. 1976
1976 Left atrial size in patients with atrial fibrillation: an echocardiographic studyAmerican Journal of the Medical Sciences.  272:57-64. 1976
1976 Three unusual complications resulting from attempted repair of partial anomalous pulmonary venous drainageChest.  69:384-387. 1976
1975 Acute rheumatic feverJ.LA.MED.SOC..  127:61-68. 1975
1975 On the QT.Journal- Louisiana State Medical Society.  127. 1975
1975 Rapid atrial stimulation for the conversion of arrhythmias.Journal- Louisiana State Medical Society.  127. 1975
1975 Bacterial Endocarditis: Occurrence on a Traumatically Ruptured Aortic ValveJournal of the American Medical Association.  233:810-811. 1975
1975 Electrocardiogram of the month.Journal- Louisiana State Medical Society.  127. 1975
1975 Electrocardiogram of the month.Journal- Louisiana State Medical Society.  127. 1975
1975 His bundle electrogram in trifascicular disease: Report of a case studied with His bundle electrogramsJournal of Electrocardiology.  8:269-273. 1975
1974 Fixation of I.V. CathetersNew England Journal of Medicine.  291:1309-1310. 1974
1974 Electrocardiogram of the monthJ.LA MED.SOC..  126:60-61. 1974
1974 Hyperactive carotid sinus reflex and his bundle electrographyJournal of Electrocardiology.  7:71-74. 1974
1974 Venospasm during cardiac catheterizationAmerican Heart Journal.  88:813. 1974
1974 Venospasm during cardiac catheterizationAmerican Heart Journal.  88:811-812. 1974
1973 Synchronized versus nonsynchronized electrocardioversionMilitary Medicine.  138:478-480. 1973
1973 Atrial injury current in pericarditis.Archives of Internal Medicine -New Series-.  131:657-662. 1973
1973 Atrial Injury Current in PericarditisArchives of Internal Medicine -New Series-.  131:657-662. 1973
1973 Renal abnormalities discovered by routine postangiography abdominal filmsAmerican Heart Journal.  86:57-60. 1973
1973 Thrombogenicity of guide wiresAmerican Journal of Cardiology.  32:943-946. 1973
1972 Interpretation of intraventricular block on a trifascicular basisGiornale Italiano di Cardiologia.  2:921-932. 1972
1972 Paroxysmal atrial tachycardia: a presenting manifestation of hyperthyroidism: case report.Military Medicine.  137:77-78. 1972
1972 Friedreich's ataxia and myocardiopathiesAmerican Heart Journal.  84:843. 1972
1972 Thirty-two cases of interventricular septal defect and aortic insufficiency. Clinical, hemodynamic and surgical featuresAmerican Journal of Medicine.  53:473-480. 1972
1971 Intracavitary Electrocardiography as a Guide to Pacemaker PositioningJournal of the American Medical Association.  216:483-485. 1971
1971 Hypertrophic obstructive cardiomyopathy and Friedreich's ataxiaAmerican Journal of Cardiology.  28:496. 1971
1971 Intermittent isolated left posterior fascicular block.American Journal of the Medical Sciences.  261:155-160. 1971
1971 Left atrial myxoma. Report of a case including hemodynamic, surgical, histologic and histochemical characteristicsAmerican Journal of Medicine.  50:113-122. 1971
1971 Salivary gland hemorrhage as a complication of anticoagulation therapyAmerican Heart Journal.  82:282-283. 1971
1970 Hypertrophic subaortic stenosis occurring in a patient with Friedreich's ataxia.American Journal of the Medical Sciences.  260:279-284. 1970
1970 Blood pressure in pulmonary fibrosis.Annals of Internal Medicine.  73:341. 1970
1970 Salivary gland hemorrhage-An unusual complication of Coumadin anticoagulationAmerican Heart Journal.  80:675-676. 1970
1968 Tuberculous pericarditis: is limited pericardial biopsy sufficient for diagnosis? Report of two cases.The American review of respiratory disease.  98:287-291. 1968
1968 Pituitary “Stone” An Unusual CalcificationJournal of the American Medical Association.  203:367. 1968
1968 Isolated massive chylopericardiumAmerican Heart Journal.  75. 1968
1967 The pulse rate in falciparum malaria: a clinical note.Military Medicine.  132:186-187. 1967

Book

Year Title Altmetric
2014 Essentials of clinical research, second edition 2014
2008 Essentials of clinical research 2008

Chapter

Year Title Altmetric
2015 Stroke and hypertension in high-risk African Americans.  71-93. 2015
2014 A focus on clinical trials.  33-74. 2014
2014 Alternative interventional study designs.  75-90. 2014
2014 Association, cause, and correlation.  345-362. 2014
2014 Bias, confounding, and effect modification (interaction).  363-372. 2014
2014 Data safety and monitoring boards (DSMBs).  193-202. 2014
2014 Grant and manuscript writing.  391-418. 2014
2014 Introduction to clinical research concepts, essential characteristics of clinical research, overview of clinical research study designs.  11-32. 2014
2014 It’s all about uncertainty.  373-390. 2014
2014 Mentoring and advising.  427-435. 2014
2014 Meta-analysis, evidence-based medicine, and clinical guidelines.  203-231. 2014
2014 Phase 4 (postmarketing) research.  91-116. 2014
2014 Presentation skills: How to present research results.  437-447. 2014
2014 Recruitment and retention in clinical research.  177-192. 2014
2014 Research methodology for studies of diagnostic tests.  313-326. 2014
2014 The beginning – historical aspects of clinical research, clinical research: Definitions, “anatomy and physiology,” and the quest for “universal truth”.  1-10. 2014
2014 The media and clinical research.  419-425. 2014
2014 The placebo and nocebo effect.  145-176. 2014
2014 The role of the USA food and drug administration in clinical research.  117-143. 2014
2008 Alternative interventional study designs.  63-71. 2008
2008 Association, cause, and correlation.  279-294. 2008
2008 Bias, confounding, and effect modification.  295-302. 2008
2008 Clinical research: Definitions, anatomy and physiology, and the quest for universal truth.  3-11. 2008
2008 Clinical trials.  29-62. 2008
2008 Data safety and monitoring boards (DSMBs).  151-158. 2008
2008 Grant writing.  317-325. 2008
2008 Introduction to clinical research and study designs.  13-27. 2008
2008 It's all about uncertainty.  303-316. 2008
2008 Mentoring and advising.  335-340. 2008
2008 Meta-analysis.  159-177. 2008
2008 Postmarketing research.  73-91. 2008
2008 Presentation skills: How to present research results.  341-349. 2008
2008 Recruitment and retention.  141-149. 2008
2008 Research methodology for studies of diagnostic tests.  245-257. 2008
2008 The United States Federal Drug Administration (FDA) and clinical research.  93-110. 2008
2008 The media and clinical research.  329-333. 2008
2008 The placebo and nocebo effect.  111-140. 2008
2005 The Placebo Effect in Cardiovascular Disease.  2-28. 2005

Principal Investigator On

  • Private Grant  awarded by Bayer HealthCare 2012 - 2017
  • Private Grant  awarded by Novartis Pharma AG 2013 - 2014
  • Private Grant  awarded by Bayer AG 2008 - 2011
  • Private Grant  awarded by FOREST RESEARCH INSTITUTE, INC. 2009 - 2011
  • Investigator On

  • Private Grant  awarded by Bayer HealthCare 2015 - 2019
  • Private Grant  awarded by ASTRAZENECA AB 2013 - 2016
  • Exploring the Impact of Negative Energy Balance in Men with Prostate Cancer  awarded by National Cancer Institute/NIH/DHHS 2012 - 2016
  • Exercise Intensity, Metabolic Rate & Insulin Sensitivity  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2010 - 2016
  • Action For Health In Diabetes Continuation (Look AHEAD)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2013 - 2016
  • Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2015
  • HyperGEN: Genetics of Left Ventricular Hypertrophy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2013 - 2015
  • REasons for Geographic And Racial Differences in Stroke-Myocardial Infarction-2  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2011 - 2015
  • UAB Pre-Doctoral Training Program in Obesity-Related Research  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2010 - 2015
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2015
  • Private Grant  awarded by Bayer HealthCare 2014 - 2015
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2013 - 2014
  • Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2008 - 2014
  • Private Grant  awarded by AMGEN, INC. 2013 - 2014
  • Longitudinal Changes in Pericardial Adiposity and Subclinical Atherosclerosis  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER 2013 - 2014
  • Clinical Center for LookAHEAD: Action for Health in Diabetes  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2006 - 2013
  • Longitudinal Changes in Pericardial Adiposity and Subclinical Atherosclerosis - Field Study  awarded by WAKE FOREST UNIVERSITY 2010 - 2013
  • Longitudinal Studies of Coronary Heart Disease Risk Factors in Young Adults-CARDIA-Field Center (Coronary Artery Risk Development in Young Adults (CARDIA) Study-Field Center and Study Follow-Up Field Center)  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 1983 - 2013
  • Hypergen: Genetics of Left Ventricular Hypertrophy  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2006 - 2013
  • Private Grant  awarded by AMGEN, INC. 2012 - 2013
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2012
  • Etiology of Geographic and Racial Differences in Stroke  awarded by National Institute of Neurological Disorders and Stroke/NIH/DHHS 2008 - 2012
  • Improvement of Visual Processing in Older Adults  awarded by National Institute on Aging/NIH/DHHS 2006 - 2012
  • Education And Training

  • Doctor of Medicine, University of Miami 1964
  • Full Name

  • Stephen Glasser